 baxter travenol labs ltbax 3rd qtr shr net shr 31 cts 18 cts net 90 mln 51 mln sales 158 billion 142 billion avg shrs 274 mln 269 mln mths shr 79 cts 42 cts net 233 mln 129 mln sales 458 billion 422 billion avg shrs 238 mln 267 mln note 1987 results include caremark august 3 caremark acquisition reduced 1987 months net cts offset ct gain sale securities 1986 quarter net excludes gains discontinued operations 12 mln dlrs cts gain sale discontinued operations 285 mln dlrs 106 dlrs charge early repayment debt 58 mln dlrs 22 cts 1986 months net excludes gains discontinued operations 38 mln dlrs 14 cts gain sale discontinued operations 285 mln dlrs 106 dlrs charge early repayment debt 58 mln dlrs 22 cts